FDA Investigator Joseph A Piechocki

Joseph A Piechocki has conducted inspections on 30 sites in 5 countries as of 10 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
30
Last Inspection Date:
10 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Italy, India, China, Jordan
FDA Investigators that have inspected at least one site in common with Joseph A Piechocki:
Adam J Wilson, Adam R Cooke, Aditi S Thakur, Adree N Anderson, Alan L Truong, Alan M Barker, Alanna L Mussawwir Bias, Alexandra A Carrico, Alicia M Mozzachio, Amanda M Dunneback, Amy S Graf, Ana Paulap Sandee, Anders W Evenson, Andrace L Deyampert, Andrea D Swingle, Andrew J Barrowcliff, Angela E Glenn, Anna M Brannen, Anthony F Lorenzo, Anthony J Ladner, Anthony R Bucks, April L Brown, April L Young, Arsen Karapetyan, Art O Czabaniuk, Aurora Miha Trifanov, Azza Talaat, Bei Y He, Benjamin J Smith, Benjamin W Anderson, Bo Chi, PhD, Brent M Dehaan, Brian A Roelofs, Brian D Nicholson, Bruce H Mccullough, Burnell M Henry, Byungja E Marciante, Caroline Strasinger, Carolyn A Warren, Carrie Ann Plucinski, CDR Rochelle B Young, RPh, MSA, Chad E Schmear, Chad W Rice, Charisse K Green, Charles I Ann, Charles L Zhou, Cheryl A Clausen, Cheryl A Grandinetti, Christian D Lynch (CDL), Christopher D Leach, Christopher T Middendorf, Colleen E Burke, Constantin Y Philopoulos, Corrine M Carter, Courtney E Hillier, Courtney R Tiegs, Daniel J Brown, David A Paterson, David J Eide, David L Miser, David Perkins, Dawn C Olenjack, Debara R Reese, Debara Reese, Deborah M Trout, Debra I Love, Debra Lboyd Seale, Denise L Burosh, Dennis E Guilfoyle, PhD, Devaughn Edwards, Dilip Devineni, PhD, Dina A Tallman, Dipesh K Shah, Donald C Obenhuber, PhD, Dr. Carmelo Rosa, Dr. Robert C Horan, MD, Dr. Zhou Chen (nmi), MD PhD, Edward E Lockwood (EEL), Eileen A Liu, Emest F Bizjak, Emilie E Kahn, Emily J Orban, Eric M Mueller, PharmD, Erika V Butler, Franklin D Heisler, Gayle S Lawson, Gregory A Berg, Gretchen Lf Trendel, Hamet M Toure, PharmD MPH, Hassan M Fakhreddine, Hector A Carrero, Howard Sklamberg, Ian L Mcwilliams, Ifueko Osemwota, Ivan E Reyes, Jacob G Lutz, Jacqueline Mdiaz Albertini, James R Evans, James W Plucinski, Janae D Price, Janis R Armedoriz, Jason F Chancey, Jazmine N Brown, Jazmine N Still, Jean Blackston Hill, Jeanne J Thai, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, Jennifer C Johnson, Jennifer S Ness, Jesse A Vazquez, Jill J Tillman, John M Seale, John N Woodall, Jonah S Ufferfilge, Joohi Castelvetere, Jose A Lopez, Joseph A Morkunas, Joseph R Strelnik, Joseph T Madak, Joslyn K Brunelle, PhD, June P Page, Justin A Boyd, Kalavati Suvarna, PhD, Karen M Montgomery (KMM), Kelley L Clark, Kenneth H Williams, Kevin A Gonzalez, Kham Phommachanh, Kristina Fillmore, Kristina Nastovski, L'oreal F Walker, Larry K Austin, Laureen F Kononen, Lauren E Sanger, Lauren E Sexton, Lauren Iacono Connors, PhD, Lauren M Lilly, PhD, Lauren N Howard, Laurie Graham, Leigh Anne Myers, Lequita M Mayhew, Lindsey Brown, PhD, Lisa Hornback, Lisa M Bellows, Lisa R Hilliar, Logan T Williams, Luella J Rossi, Luis A Dasta, Maria C Iuga, Marie A Fadden, Marissa S Henning, Marissa S Steinhagen, Martha Sullivan Myrick, Martin R Vowell, Mary L Schuckmann, Massod Rahimi, PhD, Matthew B Casale, Matthew M Schuckmann, Megan A Haggerty, Meisha R Sampson, Meisha Waters, Melina Lrodriguez Upton, Mercy Oyugi, Miah I Schneider, Michael A Charles, Michael Shanks, MS, Michael Y Philopoulos, Michele L Forster, PhD, Michele L Glendenning, Michele L Obert, Michele Perry Williams, Mihaly S Ligmond, Monica E Murie, Montgomery Montgomery, Karen M, Muna Algharibeh, Muralidhara B Gavini, PhD, Myra K Casey, Nailing Zhang, Nancy L Rolli, Neali H Lucas, Nibin Varghese, MS, Nicholas A Violand, Nicholas J Presto, Nicholas P Diorio, Nicholas Z Lu, Nicole E Knowlton, Nicole S Williams, Omotunde O Osunsanmi, Ou Ma, Paola S Barnett, Parul M Patel, Patricia A Cochran, Patricia A Mcilroy, Patricia H Dlugosz, Patrick B Cummings, Patrick C Klotzbuecher, Patsy J Domingo, Paul L Bellamy, Pei I Chu, Peng Zhou, Peter E Baker, Phung Thien Nguyen, Prabhu P Raju, Qiao Y Bobo, Rafael Padilla, Rafeeq A Habeeb, Rajiv R Srivastava, Ralph H Vocque, Ramon E Martinez, Raquel Gonzalez Rivera, Raymond T Oji, Rebecca E Dombrowski, Richard Ledwidge (nmi), PhD, Robert D Tollefsen, Robert J Ham, Robert M Barbosa, Rohn R Robertson, Rose Ashley, Ross J Grigsby, Rumany C Penn, PharmD, Russell K Riley, Saleem A Akhtar, Salwa K Poole, Sandra A Boyd, Sandra Sejdinovic, Sanket N Patel, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Scott B Laufenberg, Shafiq S Ahadi, Shalonda C Clifford, Sharon K Thoma, PharmD, Sherry G Bous, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Simone E Pitts, Sixto M Mercado Rios, Sneha S Patel, Stephen C Mahoney, Stephen D Brown, Stephen D Eich, Steven D Kehoe, Susan D Yuscius, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Suyang Qin, Tamil Arasu, PhD, Tara L Greene, Tara L King, Tenzin Jangchup, Teresa I Navas, That Q Dang, Theodore N Sietsema, Thomas J Arista, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Tina M Pawlowski, Tina S Roecklein, Vincent Thomas, Walden H Lee, Warren J Lopicka, Wayne D Mcgrath, Wayne E Seifert, William A Warnick, William D Tingley, Xiaoshi N Wang, Yangmin Ning, Yehualashet A Gessesse, Yiyue Zhang (nmi), PhD, Yongmin Liu, Yuanyuan Li, Yumi J Hiramine, Yvonne E Lozano, Zhang Zhao, PhD

Joseph A Piechocki's Documents

Publish Date Document Type Title
October, 2022 FDA 483 Eli Lilly and Company - Form 483, 2022-10-21
September, 2023 FDA 483 AstraZeneca Pharmaceuticals LP - Form 483, 2023-09-19
July, 2021 FDA 483 ENDO USA, Inc. - Form 483, 2021-07-20
August, 2023 FDA 483 Zhuhai United Laboratories Co., Ltd. - Form 483, 2023-08-03
April, 2023 FDA 483 ENDO USA, Inc. - Form 483, 2023-04-14
June, 2023 FDA 483 Legacy Pharmaceutical Packaging, LLC - Form 483, 2023-06-30
January, 2023 FDA 483 LXR Biotech - Form 483, 2023-01-20
September, 2022 FDA 483 Element Materials Technology Ann Arbor LLC - Form 483, 2022-09-09
March, 2023 EIR Patheon Biologics LLC - EIR, 2023-03-02
August, 2022 FDA 483 Birchwood Laboratories LLC - Form 483, 2022-08-19
March, 2023 FDA 483 Response Patheon Biologics LLC - Form 483R, 2023-03-02
July, 2021 FDA 483 Response Grand River Aseptic Manufacturing Inc. - Form 483R, 2021-07-26
June, 2024 FDA 483 Dr Reddy's Laboratories Limited - Form 483, 2024-06-07
June, 2024 FDA 483 Cipla Ltd. - Form 483, 2024-06-21
October, 2022 EIR Eli Lilly and Company - EIR, 2022-10-21
February, 2024 FDA 483 Zoetis LLC - Form 483, 2024-02-13
July, 2021 FDA 483 Grand River Aseptic Manufacturing Inc. - Form 483, 2021-07-02
January, 2023 FDA 483 CofixRX, LLC - Form 483, 2023-01-20
July, 2021 EIR Grand River Aseptic Manufacturing Inc. - EIR, 2021-07-02
December, 2022 FDA 483 Amsino Healthcare (USA) Inc. - Form 483, 2022-12-19
December, 2023 FDA 483 ZYDUS LIFESCIENCES LIMITED - Form 483, 2023-12-22
November, 2021 FDA 483 Fagron Inc - Form 483, 2021-11-18
September, 2023 FDA 483 Response AstraZeneca Pharmaceuticals LP - Form 483R, 2023-10-09
December, 2023 FDA 483 LAURUS SYNTHESIS PRIVATE LIMITED - Form 483, 2023-12-12
September, 2021 FDA 483 SpecGx LLC - Form 483, 2021-09-17
March, 2023 FDA 483 Patheon Biologics LLC - Form 483, 2023-03-02
June, 2022 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2022-06-30
April, 2022 FDA 483 LGM PHARMA, LLC - Form 483, 2022-04-08
November, 2022 FDA 483 Corium Innovations, Inc - Form 483, 2022-11-18
September, 2024 FDA 483 Granules India Limited - Form 483, 2024-09-06

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more